Investigating brain function in anorexia and bulimia nervosa

Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa

Observational University of California, San Diego · NCT05056597

This study is trying to see how the brains of women with anorexia and bulimia respond to rewards compared to healthy women, using brain scans while they do tasks and eat a meal.

Quick facts

Study typeObservational
Enrollment252 (estimated)
Ages18 Years to 39 Years
SexFemale
SponsorUniversity of California, San Diego Academic / other
Locations1 site (La Jolla, California)
Trial IDNCT05056597 on ClinicalTrials.gov

What this trial studies

This observational study aims to explore the brain areas involved in 'liking', 'wanting', and learning in adults with anorexia nervosa and bulimia nervosa using advanced brain imaging techniques. It will involve 252 women aged 18-39, including those with different types of eating disorders and healthy controls. Participants will undergo functional magnetic resonance imaging (fMRI) while engaging in computer tasks, a test meal, and completing self-report questionnaires and interviews. The study will assess neural differences in reward processing and how these relate to clinical symptoms over time.

Who should consider this trial

Good fit: Ideal candidates include women aged 18-39 who meet DSM-V criteria for anorexia nervosa or bulimia nervosa.

Not a fit: Patients with psychotic illnesses, substance dependence, or other significant medical conditions may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance understanding of the neurobiological mechanisms underlying eating disorders, potentially leading to improved treatment strategies.

How similar studies have performed: Other studies have shown promising results in understanding brain function in eating disorders, making this approach both relevant and potentially impactful.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

Eating Disorder Group:

* Between the ages of 18 and 39 years old
* Meet DSM-V criteria for AN-R, AN-BP, or BN

Healthy Control Group:

* Between the ages of 18 and 39 years old
* Have maintained 85% to 120% ideal body weight since menarche

Exclusion Criteria:

All Groups:

* Psychotic illness/other mental illness requiring hospitalization
* Current dependence on drugs or alcohol defined by DSM IV criteria. Additionally, positive test results for drug use on the day of the scan, apart of marijuana, will result in cancelling or rescheduling the scan because acute use will impact MRI measures.
* Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight
* Neurological disorder, neurodevelopmental disorder, or history of head injury with \>30 min loss of consciousness
* Any contraindication to undergoing an MRI
* Primary obsessive compulsive disorder or primary major depressive disorder

Additional Exclusion Criteria for ED Group:

-If taking other psychotropic medication, any change in dosage in the 2 weeks before scanning

Additional Exclusion Criteria for Healthy Control Group:

* Meet criteria for the diagnosis of any psychiatric disorder currently
* Any history of binge eating or purging behaviors, including self-induced vomiting, laxative or diuretic misuse
* Use of any psychoactive or other medication known to affect mood or concentration in the last 3 months

Where this trial is running

La Jolla, California

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Anorexia NervosaBulimia Nervosa
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.